Yanni J M, Foxwell M H, Whitman L L
Department of Pharmacology, A.H. Robins Research Laboratories, Richmond, Va.
Int Arch Allergy Appl Immunol. 1988;87(4):430-4. doi: 10.1159/000234714.
The effect of orally administered H1 and H2 antihistamines on antigen-induced changes in tracheal mucous gel layer thickness of actively sensitized rats was determined. Cimetidine and ranitidine, H2 antagonists, produced dose-dependent inhibition of antigen-induced increase in gel thickness at doses ranging from 0.32 to 3.16 and from 0.10 to 1.0 mg/kg, respectively. H1 antagonists - like chlorpheniramine, diphenhydramine, and pyrilamine which possess anticholinergic properties - tended to enhance the antigen-induced gel thickening in a dose-dependent fashion, while astemizole and terfenadine had no effect. These data indicate that an antigen-induced increase of rat tracheal mucous gel layer thickness may result from stimulation of the H2 receptor, while histamine operating at the H1 receptor does not play a role. Therefore, an antihistamine that possesses both H1 and H2 antagonist properties while lacking anticholinergic properties appears to be the most appropriate for use in patients with asthma and associated bronchorrhea.
研究了口服H1和H2抗组胺药对主动致敏大鼠抗原诱导的气管黏液凝胶层厚度变化的影响。H2拮抗剂西咪替丁和雷尼替丁,分别在0.32至3.16mg/kg和0.10至1.0mg/kg的剂量范围内,对抗原诱导的凝胶厚度增加产生剂量依赖性抑制。具有抗胆碱能特性的H1拮抗剂,如氯苯那敏、苯海拉明和吡苄明,倾向于以剂量依赖性方式增强抗原诱导的凝胶增厚,而阿司咪唑和特非那定则无作用。这些数据表明,抗原诱导的大鼠气管黏液凝胶层厚度增加可能是由H2受体刺激引起的,而作用于H1受体的组胺不起作用。因此,一种兼具H1和H2拮抗剂特性且缺乏抗胆碱能特性的抗组胺药似乎最适合用于哮喘及相关支气管溢液患者。